Cancer Drugs Aim at More Targets
Good article from Wired on the new cancer drugs coming to market soon. “These drugs represent the next generation of anti-angiogenesis drugs beyond Avastin,” said William Li, president and medical director of the Angiogenesis Foundation, a non-profit institution based in Cambridge, Massachusetts. “If chemotherapy is like a dirty bomb and Avastin like a smart bomb, then the new therapies are more like cluster bombs that have multiple targets.”